Diabetes Tech Player DexCom Lays Out 2030 Growth Vision - DexCom (NASDAQ:DXCM)

DexCom Sets 2030 Margin Targets, Projects Double-Digit Revenue Growth, Authorizes $1 Billion Share Buyback

Raccontata dabenzinga.com